Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.

Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.

BACKGROUND:Given the high prevalence of cognitive impairment in Parkinson's disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson's d...

Full description

Bibliographic Details
Main Authors: Sophie Fengler, Josef Kessler, Lars Timmermann, Alexandra Zapf, Saskia Elben, Lars Wojtecki, Oliver Tucha, Elke Kalbe
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4954721?pdf=render

Internet

http://europepmc.org/articles/PMC4954721?pdf=render

Similar Items